Poxviruses

Poxviruses

Biodefense Headlines – 30 December 2024

News Scan December 30, 2024

This week’s selections include California’s declaration of a bird flu emergency (and calls to do so nationally), the first severe case of H5N1 in the U.S., the risks of advancing…

Bavarian Nordic Highlights Smallpox Orders, Vaccine Development

Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi

Smallpox Vaccine Potency Testing

CNN to Debut ‘Unseen Enemy’ Special on Pandemics

CDC Program Helps Democratic Republic of the Congo Combat Monkeypox

HHS Releases 2016 PHEMCE Strategy and Implementation Plan

Smallpox Research Blurs Line Between Ancient Diseases, Emerging Infections

Intravenous Brincidofovir May Improve Countermeasure’s Tolerability

Bavarian Nordic Provides 2016 Update

Canadian Government Orders Additional Smallpox Vaccine

DoD Medical Countermeasure Systems Broad Agency Announcement

PharmAthene Receives 5M Initial Payment from SIGA

Phase 1 Trial Begins for IV Version of Smallpox Drug

SIGA Gets Greenlight on Smallpox Drug Phase 3 Trial

Chickenpox Vaccine May Increase Shingles Cases in Young Adults

U.S. Government Places 133M Smallpox Vaccine Order

U.S. Moves Forward with Stockpiling of Second Smallpox Antiviral

Smallpox Vaccine Performs Well in Two Pivotal Studies

Misconceptions About Smallpox’s Role in Native Depopulation

Smallpox Vaccine Virus Helps UNL Scientist Understand Immunity

Biodefense Headlines – 30 December 2024